Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (414) Arrow Down
Filter Results: (414) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,400)
    • Faculty Publications  (414)

    Show Results For

    • All HBS Web  (1,400)
      • Faculty Publications  (414)

      Health FinancingRemove Health Financing →

      ← Page 12 of 414 Results →

      Are you looking for?

      →Search All HBS Web
      • October 2016 (Revised March 2019)
      • Case

      Carrum Health: Scaling Bundled Payments

      By: Robert S. Huckman and Sarah Mehta
      Founded in 2014, Carrum Health helped self-insured employers located in three markets (San Diego, California; Seattle, Washington; and San Francisco, California) save money on their employees’ planned surgeries. It did so by contracting directly with top-quality... View Details
      Keywords: Health Financing; Health Insurance; Value-based Healthcare Reimbursements; Bundled Payments; Innovation; Scale; Health; Health Care and Treatment; Cost Management; Growth and Development Strategy; Decision Choices and Conditions; Health Industry; California; San Francisco; San Diego; Seattle
      Citation
      Educators
      Purchase
      Related
      Huckman, Robert S., and Sarah Mehta. "Carrum Health: Scaling Bundled Payments." Harvard Business School Case 617-017, October 2016. (Revised March 2019.)
      • Article

      Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry

      By: Leemore S. Dafny, Christopher Ody and Matt Schmitt
      The analogy between value-based purchasing in pharmaceuticals and the new frontier of alternative payment models for health care providers is relatively straightforward. Insurers are increasingly demanding steep discounts from providers in exchange for inclusion in... View Details
      Keywords: Drug Copayment Coupons; Prescription Drug Policy; Health Care and Treatment; Insurance; Cost; Policy; Pharmaceutical Industry
      Citation
      Find at Harvard
      Read Now
      Related
      Dafny, Leemore S., Christopher Ody, and Matt Schmitt. "Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry." New England Journal of Medicine 375, no. 21 (November 24, 2016): 2013–2015.
      • July 2016 (Revised July 2019)
      • Teaching Plan

      Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

      By: Nori Gerardo Lietz and Ricardo Andrade
      In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
      Keywords: Health Care; Mergers & Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Health Industry; Health Industry; Health Industry; United States
      Citation
      Purchase
      Related
      Lietz, Nori Gerardo, and Ricardo Andrade. "Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)." Harvard Business School Teaching Plan 217-003, July 2016. (Revised July 2019.)
      • July–August 2016
      • Article

      How to Pay for Health Care

      By: Michael E. Porter and Robert S. Kaplan
      The United States stands at a crossroads in how to pay for health care. Fee for service, the dominant model in the United States and many other countries, is now widely recognized as perhaps the biggest obstacle to improving health care delivery. A battle is currently... View Details
      Keywords: Health Care and Treatment; Finance; Health Industry; United States
      Citation
      Find at Harvard
      Register to Read
      Related
      Porter, Michael E., and Robert S. Kaplan. "How to Pay for Health Care." Harvard Business Review 94, nos. 7-8 (July–August 2016): 88–100.
      • June 2016
      • Teaching Plan

      Terrapin Laboratory

      By: Joseph B. Fuller and Andrew Otazo
      This teaching plan accompanies the case "Terrapin Laboratory," HBS No. 315-098. That case describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug... View Details
      Keywords: Business Growth; Entrepreneurial Management; Growth Strategy; Market Entry; Venture Capital; Market Entry and Exit; Entrepreneurship; Health Testing and Trials; Growth and Development Strategy; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Fuller, Joseph B., and Andrew Otazo. "Terrapin Laboratory." Harvard Business School Teaching Plan 316-183, June 2016.
      • Article

      Time-Driven Activity-Based Costing in Emergency Medicine

      By: Robert S. Kaplan, Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey and Ali S. Raja
      Value in emergency medicine is determined by both patient-important outcomes and the costs associated with achieving them. However, measuring true costs is challenging. Without an understanding of costs, emergency department (ED) leaders will be unable to determine... View Details
      Keywords: Time-Driven Activity-Based Costing; Emergency Room; Health Care and Treatment; Value; Cost Management; Activity Based Costing and Management
      Citation
      Read Now
      Related
      Kaplan, Robert S., Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey, and Ali S. Raja. "Time-Driven Activity-Based Costing in Emergency Medicine." Annals of Emergency Medicine 67, no. 6 (June 2016): 765–772.
      • April 2016 (Revised July 2019)
      • Case

      "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

      By: Nori Gerardo Lietz
      In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
      Keywords: Health Care; Mergers & Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Health Industry; Health Industry; Health Industry; United States
      Citation
      Educators
      Related
      Lietz, Nori Gerardo. "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A). Harvard Business School Case 216-021, April 2016. (Revised July 2019.)
      • March 2016 (Revised March 2022)
      • Teaching Note

      Evive Health and Workplace Influenza Vaccinations

      By: John Beshears
      Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective messages that improve individuals' health... View Details
      Keywords: Vaccination; Influenza; Flu Shot; Preventive Care; Health Care; Behavioral Economics; Choice Architecture; Nudge; Experimental Design; Randomized Controlled Trial; RCT; Causal Inference; Health Care and Treatment; Insurance; Health; Consumer Behavior; Health Testing and Trials; Communication Strategy; Health Industry; Health Industry
      Citation
      Purchase
      Related
      Beshears, John. "Evive Health and Workplace Influenza Vaccinations." Harvard Business School Teaching Note 916-049, March 2016. (Revised March 2022.)
      • Article

      Value-based Healthcare: Implications for Thyroid Cancer

      By: A.K. Ying, T.W. Feeley and M. E. Porter
      Today's delivery of care to thyroid cancer patients is complex, and costly, with uneven outcomes that can be improved. The incidence of thyroid cancer is rising and requires coordinated, multidisciplinary care with high volume centers that is not always available in... View Details
      Keywords: Bundled Reimbursement; Healthcare Reform; Integrated Practice Units; Outcomes; Patient-reported Outcomes; Thyroid Cancer; Health Care and Treatment; Cost; Information Technology; Value
      Citation
      Register to Read
      Related
      Ying, A.K., T.W. Feeley, and M. E. Porter. "Value-based Healthcare: Implications for Thyroid Cancer." International Journal of Endocrine Oncology 3, no. 2 (May 2016): 115–129. (e-Pub 4/2016.)
      • February 2016 (Revised September 2017)
      • Case

      Mohamed Azab and Seha Capital

      By: Richard G. Hamermesh and Sarah McAra
      In January 2011, Mohamed Azab, founder and CEO of health care investment firm Seha Capital, made his first health care investment in Hassab Labs, a diagnostic lab in Alexandria, Egypt. Weeks later, a revolution erupted across the country as the Arab Spring swept... View Details
      Keywords: Health Care; Health; Pan-Africa; Health Care Investment; Financing; Developing World; Entrepreneurship; Health Care and Treatment; Investment; Financing and Loans; Developing Countries and Economies; Egypt; Africa
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and Sarah McAra. "Mohamed Azab and Seha Capital." Harvard Business School Case 816-066, February 2016. (Revised September 2017.)
      • 2016
      • Teaching Note

      Advanced Leadership Pathways: General Gale Pollock and Services for the Vision Impaired

      By: Rosabeth M. Kanter, Tessa Natanay Hamilton and Ai-Ling Jamila Malone
      Teaching note for case 314029. Following a successful military career as an Army Nurse, achieving rank as Major General, becoming the first female Acting Surgeon General of the Army, and the 22nd Chief of the Army Nurse Corps, Pollock developed a vested interest in... View Details
      Keywords: Health Care; Health Care Education; Insurance Companies; Military; Leadership Skills; Health Care and Treatment; Education; Insurance; Business Startups; Information Technology; Applications and Software; Change Management; Health Industry; Health Industry
      Citation
      Purchase
      Related
      Kanter, Rosabeth M., Tessa Natanay Hamilton, and Ai-Ling Jamila Malone. "Advanced Leadership Pathways: General Gale Pollock and Services for the Vision Impaired." Harvard Business Publishing Teaching Note 316-036, 2016. (Harvard Advanced Leadership Initiative.)
      • 2015
      • Case

      Advanced Leadership Pathways: Mike Critelli and Dossia Service Corporation

      By: Rosabeth Moss Kanter and Patricia Bissett Higgins
      In 2010, Mark Critelli was a well-seasoned corporate executive who had recently transitioned from being the CEO of a Fortune 500 company to that of a startup called Dossia. As an AL Fellow, he knew that despite believing in Dossia’s mission to empower individuals with... View Details
      Keywords: Health And Wellness; Health Care; Health Care Education; Health Care Entrepreneurship; Health Care Industry; Health Care Investment; Health Care Outcomes; Health Care Quality; Health Care Reform; Health Care Services; Health Costs; Preventive Care; Insurance Companies; Insurance Industry; Employee Compensation; Empoylee Wellness Programs; Patient Reported Outcome Measures; Patient Satisfaction; Data; Data Analytics; Entrepreneurs; Entrepreneurial Organizations; Entrepreneurial Ventures; Start-up; Leadership Skills; Disruptive Change; Health; Insurance; Employees; Leadership; Disruptive Innovation; Health Care and Treatment; Employment; Entrepreneurship; Business Startups; Information Technology; Analytics and Data Science; Health Industry; United States
      Citation
      Purchase
      Related
      Kanter, Rosabeth Moss, and Patricia Bissett Higgins. "Advanced Leadership Pathways: Mike Critelli and Dossia Service Corporation." Harvard Business Publishing Case 316-053, 2015. (Harvard Advanced Leadership Initiative.)
      • October 22, 2015
      • Article

      The Mayo Clinic Model for Running a Value-Improvement Program

      By: Robert S. Kaplan, Derek A. Haas, Richard A. Helmers, March Rucci and Meredith Brady
      Applying time-driven activity-based costing (TDABC) in health care cannot be delegated to the finance function. The most successful implementations have had strong executive support, exceptional clinical leaders, and dedicated, multi-disciplinary project teams. The... View Details
      Keywords: Service Delivery; Activity Based Costing and Management; Health Care and Treatment; Health Industry
      Citation
      Register to Read
      Related
      Kaplan, Robert S., Derek A. Haas, Richard A. Helmers, March Rucci, and Meredith Brady. "The Mayo Clinic Model for Running a Value-Improvement Program." Harvard Business Review (website) (October 22, 2015). (A collaboration of the editors of Harvard Business Review and the New England Journal of Medicine.)
      • Article

      Behavioral Hazard in Health Insurance

      By: Katherine Baicker, Sendhil Mullainathan and Joshua Schwartzstein
      A fundamental implication of standard moral hazard models is overuse of low-value medical care because copays are lower than costs. In these models, the demand curve alone can be used to make welfare statements, a fact relied on by much empirical work. There is ample... View Details
      Keywords: Insurance; Consumer Behavior; Health Care and Treatment; Insurance Industry
      Citation
      Find at Harvard
      Read Now
      Purchase
      Related
      Baicker, Katherine, Sendhil Mullainathan, and Joshua Schwartzstein. "Behavioral Hazard in Health Insurance." Quarterly Journal of Economics 130, no. 4 (November 2015): 1623–1667. (Online Appendix.)
      • June 2015
      • Teaching Note

      Schӧn Klinik: Measuring Cost and Value

      By: Robert S. Kaplan
      Teaching Note for Schon Klinik: Measuring Cost and Value. View Details
      Keywords: Health Care and Treatment; Cost Management; Projects; Health Industry; Germany
      Citation
      Purchase
      Related
      Kaplan, Robert S. "Schӧn Klinik: Measuring Cost and Value." Harvard Business School Teaching Note 115-066, June 2015.
      • May 2015 (Revised September 2015)
      • Case

      AIP Healthcare Japan: Investing in Japan's Retirement Home Market

      By: John A. Quelch and Qing Xia
      The CEO of a health care-based REIT is considering alternative nursing home investment strategies. Students must consider macro-industry trends, scale and scope issues and consumer segmentation data in making their recommendations. View Details
      Keywords: Health Care; Health Care Services; REIT; Marketing; Investment; Health Care and Treatment; Segmentation; Health Industry; Health Industry; Health Industry; Japan
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Qing Xia. "AIP Healthcare Japan: Investing in Japan's Retirement Home Market." Harvard Business School Case 515-102, May 2015. (Revised September 2015.)
      • March 2015 (Revised November 2017)
      • Case

      Bonitas

      By: Regina E. Herzlinger and Natalie Kindred
      Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas... View Details
      Keywords: Health Insurance; Health Care; South Africa; Medical Scheme; Public Policy; Bonitas; Bonitas Medical Fund; National Health Insurance; Health; Health Care and Treatment; Insurance; Policy; Health Industry; Health Industry; South Africa; Johannesburg; Africa
      Citation
      Educators
      Purchase
      Related
      Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
      • March 2015 (Revised January 2024)
      • Case

      CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies

      By: Regina E. Herzlinger and Andrew Otazo
      Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
      Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Health Industry; United States; Europe
      Citation
      Educators
      Purchase
      Related
      Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
      • March 2015 (Revised September 2016)
      • Case

      Terrapin Laboratory

      By: Richard G. Hamermesh and Joseph B. Fuller
      Describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. The associated teaching materials provide students the opportunity... View Details
      Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Growth Management; Expansion; Financing and Loans; Health Care and Treatment; Health Testing and Trials; Business Startups; Health Industry; Health Industry
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and Joseph B. Fuller. "Terrapin Laboratory." Harvard Business School Case 315-098, March 2015. (Revised September 2016.)
      • February 2015
      • Supplement

      The Affordable Care Act (C): Legislative Strategy in the Senate

      By: Joseph L. Bower and Michael Norris
      In 2009, the Senate begins drafting its health care bills. Jurisdiction in the Senate is shared between two committees, but the more important is the Senate Finance Committee. View Details
      Keywords: Health Care; Health Care Policy; Government And Politics; Health; Government Administration; Health Industry; United States
      Citation
      Purchase
      Related
      Bower, Joseph L., and Michael Norris. "The Affordable Care Act (C): Legislative Strategy in the Senate." Harvard Business School Supplement 315-034, February 2015.
      • ←
      • 12
      • 13
      • …
      • 20
      • 21
      • →

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.